Cisplatin versus carboplatin in association with third-generation drugs for advanced non-small cell lung cancer

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of carboplatin-based chemotherapy when compared with cisplatin-based chemotherapy, both in association with a third-generation drug, in patients with advanced NSCLC. We will also compare quality of life in patients with advanced NSCLC receiving chemotherapy with cisplatin and carboplatin combined with a third-generation drug.